[{"NetIncomeLossConverted_4_FY_USD":3513200000.0,"NetIncomeLossConverted_1_FY_USD":1149200000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":107600000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":2618100000.0,"EarningsPerShareDiluted_1_FY_USD":10.24,"EarningsPerShareDiluted_4_FY_USD":30.52,"StockholdersEquity_0_FY_USD":11025300000.0,"RevenuesConverted_1_FY_USD":2422900000.0,"RevenuesConverted_4_FY_USD":8497100000.0,"Assets_0_FY_USD":17163300000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":115100000.0,"EarningsPerShareBasic_4_FY_USD":32.65,"EarningsPerShareBasic_1_FY_USD":10.9,"Ticker":"REGN","CIK":"872589","name":"REGENERON PHARMACEUTICALS, INC.","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"4","uom":"USD","footnote":"nan","Market Cap":"77738004554.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20210208"}]